OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE tablet, film coated United States - English - NLM (National Library of Medicine)

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet, film coated

teva pharmaceuticals usa, inc. - olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10), amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - olmesartan medoxomil 20 mg - olmesartan medoxomil, amlodipine, hydrochlorothiazide tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE 20/5/12.5 MG- olmesartan medoxomil, amlodipine and hydrochlorothiazide United States - English - NLM (National Library of Medicine)

olmesartan medoxomil, amlodipine and hydrochlorothiazide 20/5/12.5 mg- olmesartan medoxomil, amlodipine and hydrochlorothiazide

torrent pharmaceuticals limited - olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10), amlodipine (unii: 1j444qc288) (amlodipine - unii:1j444qc288), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - olmesartan medoxomil 20 mg - olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, su

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE- olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide tabl United States - English - NLM (National Library of Medicine)

olmesartan medoxomil, amlodipine and hydrochlorothiazide- olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide tabl

sun pharmaceutical industries, inc. - olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10), amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - olmesartan medoxomil 20 mg - olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, su

OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE tablet, film coated United States - English - NLM (National Library of Medicine)

olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide tablet, film coated

par pharmaceutical, inc. - olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10), amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - olmesartan medoxomil 20 mg - olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, su

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 20 mg/5 mg/12.5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide clonmel 20 mg/5 mg/12.5 mg film-coated tablets

clonmel healthcare ltd - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 20 mg/5 mg/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 40 mg/10 mg/12.5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide clonmel 40 mg/10 mg/12.5 mg film-coated tablets

clonmel healthcare ltd - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40 mg/10 mg/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 40 mg/10 mg/25 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide clonmel 40 mg/10 mg/25 mg film-coated tablets

clonmel healthcare ltd - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40 mg/10 mg/25 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 40 mg/5 mg/12.5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide clonmel 40 mg/5 mg/12.5 mg film-coated tablets

clonmel healthcare ltd - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40 mg/5 mg/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 40 mg/5 mg/25 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide clonmel 40 mg/5 mg/25 mg film-coated tablets

clonmel healthcare ltd - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40 mg/5 mg/25 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 40 mg/10 mg/25 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide krka 40 mg/10 mg/25 mg film-coated tablets

krka, d.d., novo mesto - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40/10/25 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide